Quantcast

Latest Raloxifene Stories

2006-04-17 13:27:51

WASHINGTON (Reuters) - Eli Lilly and Co's Evista osteoporosis drug works as well as the older tamoxifen in reducing the risk of breast cancer in high-risk women, with fewer dangerous side effects, researchers said on Monday. The results of the 19,000-woman Study of Tamoxifen and Raloxifene (STAR) trial show that Evista, known generically as raloxifene, is less likely than tamoxifen to cause blood clots and uterine cancer. "In STAR, both drugs reduced the risk of developing invasive...

2006-04-17 13:16:37

WASHINGTON (Reuters) - Evista, Eli Lilly and Co's osteoporosis drug, works just as well as the older drug tamoxifen in reducing the risk of breast cancer in high-risk women, and without some of the dangerous side-effects, researchers said on Monday. The results of the 19,000-woman Study of Tamoxifen and Raloxifene (STAR) trial show that Evista, known generically as raloxifene, is less likely to cause blood clots and uterine cancer, yet like tamoxifen lowers the risk of breast cancer...

2006-04-17 13:24:38

WASHINGTON (Reuters) - Eli Lilly and Co's Evista osteoporosis drug works as well as the older tamoxifen in reducing the risk of breast cancer in high-risk women, with fewer dangerous side effects, researchers said on Monday. The results of the 19,000-woman Study of Tamoxifen and Raloxifene (STAR) trial show that Evista, known generically as raloxifene, is less likely than tamoxifen to cause blood clots and uterine cancer. "In STAR, both drugs reduced the risk of developing invasive...

2006-04-17 13:09:07

WASHINGTON (Reuters) - Evista, Eli Lilly and Co's osteoporosis drug, works just as well as the older drug tamoxifen in reducing the risk of breast cancer in high-risk women, and without some of the dangerous side-effects, researchers said on Monday. The results of the 19,000-woman Study of Tamoxifen and Raloxifene (STAR) trial show that Evista, known generically as raloxifene, is less likely to cause blood clots and uterine cancer, yet like tamoxifen lowers the risk of breast cancer...

2005-12-29 15:20:24

NEW YORK (Reuters Health) - A small study has shown that the osteoporosis drug raloxifene, sold as Evista, helps maintain bone mineral density (BMD) in menopausal women with systemic lupus erythematosus (SLE) who are on corticosteroids. SLE is a chronic autoimmune disease in which the immune system can confuse healthy and foreign tissues and sometimes attacks both. The disorder disproportionately affects women. SLE may be treated with steroids and long-term treatment with steroids...

2005-12-21 08:52:48

BOSTON (Reuters) - Eli Lilly and Co. said on Wednesday it will plead guilty to a misdemeanor violation as part of a settlement with the government over its marketing and promotional practices for an osteoporosis drug. The investigation, which began in July 2002, led to government charges that in 1998 certain Lilly employees promoted the company's drug Evista to prevent and reduce the risk of breast cancer and certain heart problems. While doctors are allowed to prescribe drugs for...

3ee85fd4f90f148df8095c7f9afe20de1
2005-12-09 09:32:22

A belief that illness is 'meant to be' can prove deadly, experts say A cancer diagnosis can present the average person with the battle of his or her life. But new research suggests too many may be giving up on that fight far too early. One example: In a recent effort to recruit high-risk black and Hispanic New Yorkers to a breast cancer prevention drug trial, researchers at Columbia University asked each potential candidate whether or not she agreed with the statement, "If someone is meant to...

2005-11-15 16:39:54

By Susan Heavey WASHINGTON (Reuters) - Women at high risk for breast cancer who take the well-known drug tamoxifen can reduce their long-term risk of developing the disease, according to a new study released on Tuesday. Researchers found that women who took tamoxifen, sold as a generic and by AstraZeneca Plc under the brand Nolvadex, for up to five years were about 43 percent less likely to get breast cancer than those who took a placebo. Out of 6,681 women taking the drug, 145 have...

2005-11-15 16:31:30

NEW YORK (Reuters Health) - Data from additional years of follow-up of a large study of tamoxifen for the prevention of breast cancer confirm that the drug reduces the risk of the disease in high-risk women. Tamoxifen "remains the only proven chemopreventive treatment for breast cancer risk reduction," Dr. Bernard Fisher, from the University of Pittsburgh, and colleagues note in their report in the Journal of the National Cancer Institute this week. In the study, which began in...

2005-09-13 17:00:43

NEW YORK (Reuters) - Pfizer Inc. on Tuesday said U.S. regulators denied approval of its experimental osteoporosis drug Oporia, handing the world's biggest drug maker another setback in its efforts to bring lucrative, new medicines to market. Pfizer said it will review its submission with the Food and Drug Administration and was considering possible courses of action. "This is most concerning as it's the third late-stage failure they've had in the past year," said A.G. Edwards...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related